![James Bonnar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
James Bonnar is currently CEO, Non-Independent Director & MD at Nyrada, Inc. since 2025.
Formerly, Mr. Bonnar was Director-CMC & Regulatory Affairs at Neuren Pharmaceuticals (Australia) Pty Ltd.
Postes actifs de James Bonnar
| Sociétés | Poste | Début |
|---|---|---|
| NYRADA INC. | Directeur Général | 01/02/2018 |
Anciens postes connus de James Bonnar
| Sociétés | Poste | Fin |
|---|---|---|
Neuren Pharmaceuticals (Australia) Pty Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Neuren Pharmaceuticals (Australia) Pty Ltd. | |
Nyrada, Inc.
 Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs | Health Technology |
